Cargando…
Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine
Breast cancer is the most common malignancy in women throughout the world. Metastatic dissemination to vital organs is the leading cause of breast cancer-related deaths. The treatment of metastases is mainly based on the primary tumor characteristics. However, breast cancer metastases exhibit high h...
Autores principales: | Montemagno, Christopher, Pagès, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226533/ https://www.ncbi.nlm.nih.gov/pubmed/32235331 http://dx.doi.org/10.3390/cancers12040821 |
Ejemplares similares
-
Theranostic Advances in Breast Cancer in Nuclear Medicine
por: Vahidfar, Nasim, et al.
Publicado: (2021) -
Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?
por: Montemagno, Christopher, et al.
Publicado: (2021) -
Theranostics in nuclear medicine practice
por: Yordanova, Anna, et al.
Publicado: (2017) -
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
por: Montemagno, Christopher, et al.
Publicado: (2020) -
Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future
por: Echavidre, William, et al.
Publicado: (2023)